---
title: "The Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014"
id: f403edd3-af79-4679-a10b-37cfa02c2139
authority: uk
place: "United Kingdom"
applies_also_from: []
kind: regulation
in_force: true
publisher_url: https://www.legislation.gov.uk/uksi/2014/3277
attribution: "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
solon_url: https://solon.orangecat.ch/law/f403edd3-af79-4679-a10b-37cfa02c2139
language: en
in_force_from: 2015-01-07
date_basis: publisher
status: consolidated
source_url: https://www.legislation.gov.uk/uksi/2014/3277/data.xml
read_on: 2026-11-10
sha256: ad0fa653029eb1e45f06ef7b24e5f8fed655dfb085f612420a592eb104ca53fb
provisions: 7
---

# The Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014

## Title and introductory text {#prelims}

2014 No. 3277
Dangerous Drugs, England And Wales
Dangerous Drugs, Scotland
The Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014
Made
11th December 2014
Laid before Parliament
17th December 2014
Coming into force
7th January 2015
The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971.
In accordance with section 31(3) of that Act the Secretary of State has consulted with the Advisory Council on the Misuse of Drugs.

## 1 Citation, commencement and extent {#regulation-1}

(1) These Regulations may be cited as the Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014 and come into force on 7th January 2015.
(2) These Regulations extend to England and Wales and Scotland.

## 2 Amendment of the Misuse of Drugs Regulations 2001 {#regulation-2}

The Misuse of Drugs Regulations 2001 are amended as follows.

## 3 Amendment of the Misuse of Drugs Regulations 2001 {#regulation-3}

In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—
(a) after “Tenocyclidine” insert—
(6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52)
;
(b) after “4-bromo-2,5-dimethoxy-a-methylphenethylamine” insert—
3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)
(6aR,9R)-N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD)
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD)
(6aR,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD)
;
(c) after “2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol” insert—
2,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone (LSZ)
.

## 4 Amendment of the Misuse of Drugs Regulations 2001 {#regulation-4}

For paragraph 1(b) of Schedule 1, substitute—
(b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say—
(i) by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;
(ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;
(iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;
(iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent;
.

## 5 Amendment of the Misuse of Drugs Regulations 2001 {#regulation-5}

In Schedule 2 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27) after “Hydropmorphone” insert—
4-Hydroxy-n-butyric acid
.

## 6 Amendment of the Misuse of Drugs Regulations 2001 {#regulation-6}

In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) omit “4-Hydroxy-n-butyric acid”.